Skip to content

Q4 FY24 Earnings Results

Q4 FY24 earnings, Jan–Mar 2024: 5,481 Indian listed companies have reported; median profit growth is 0.0% on last year. Quarter ended 31 Mar 2024.

Clear filters 1–100 of 243
CompanyRevenue (₹ Cr)Profit (₹ Cr)Per share8Q profit
Symbol Sector Reported YoY QoQ Reported YoY EPS vs consensus Trend
SUNPHARMA Sun Pharmaceutical Industries LtdHealthcare11,983n/adown−3.2%2,659n/a11.06No estimate
AUROPHARMA Aurobindo Pharma LtdHealthcare7,580n/aup+3.1%907n/a15.51No estimate
DRREDDY Dr Reddys Laboratories LtdHealthcare7,114n/adown−1.7%1,310n/a15.70No estimate
CIPLA Cipla LtdHealthcare6,163n/adown−6.7%932n/a11.63No estimate
ZYDUSLIFE Zydus Lifesciences LtdHealthcare5,534n/aup+22.8%1,246n/a11.75No estimate
LUPIN Lupin LtdHealthcare4,961n/adown−4.5%368n/a7.89No estimate
BIOCON Biocon LtdHealthcare3,917n/adown−0.9%223n/a1.13No estimate
GLENMARK Glenmark Pharmaceuticals LtdHealthcare3,063n/aup+22.2%−1,214n/a−43.17No estimate
ALKEM Alkem Laboratories LtdHealthcare2,936n/adown−11.7%304n/a24.55No estimate
TORNTPHARM Torrent Pharmaceuticals LtdHealthcare2,745n/aup+0.5%449n/a13.27No estimate
PPLPHARMA Piramal Pharma LtdHealthcare2,552n/aup+30.3%101n/a0.77No estimate
MANKIND Mankind Pharma LtdHealthcare2,422n/adown−7.1%477n/a11.76No estimate
DIVISLAB Divis Laboratories LtdHealthcare2,303n/aup+24.2%538n/a20.27No estimate
IPCALAB Ipca Laboratories LtdHealthcare2,033n/adown−1.0%1n/a2.35No estimate
EMCURE Emcure Pharmaceuticals LtdHealthcare1,771n/aup+6.2%121n/a6.36No estimate
JUBLPHARMA Jubilant Pharmova LtdHealthcare1,759n/aup+4.9%−62n/a−3.68No estimate
GLAND Gland Pharma LtdHealthcare1,537n/adown−0.5%192n/a11.68No estimate
APLLTD Alembic Pharmaceuticals LtdHealthcare1,517n/adown−7.0%178n/a9.07No estimate
LAURUSLABS Laurus Labs LtdHealthcare1,440n/aup+20.5%75n/a1.40No estimate
ABBOTINDIA Abbott India LtdHealthcare1,439n/aup+0.1%287n/a135.09No estimate
GRANULES Granules India LtdHealthcare1,176n/aup+1.7%130n/a5.35No estimate
NATCOPHARM Natco Pharma LtdHealthcare1,068n/aup+40.7%386n/a19.69No estimate
AJANTPHARM Ajanta Pharma LtdHealthcare1,054n/adown−4.6%203n/a15.82No estimate
STAR Strides Pharma Science LtdHealthcare1,044n/aup+3.8%10n/a1.98No estimate
AKUMS Akums Drugs & Pharmaceuticals LtdHealthcare944n/adown−12.8%−39n/a−2.89No estimate
GLAXO Glaxosmithkline Pharmaceuticals LtdHealthcare930n/aup+15.5%194n/a11.48No estimate
SYNGENE Syngene International LtdHealthcare917n/aup+7.4%189n/a4.69No estimate
JBCHEPHARM J B Chemicals & Pharmaceuticals LtdHealthcare862up+13.1%up+2.0%126up+43.2%8.13No estimate
WOCKPHARMA Wockhardt LtdHealthcare700n/adown−0.1%−177n/a−11.02No estimate
INDGN Indegene LtdHealthcare673n/a0.0%95n/a4.26No estimate
DCAL Dishman Carbogen Amcis LtdHealthcare655n/aup+0.6%−70n/a−4.46No estimate
AARTIDRUGS Aarti Drugs LtdHealthcare620n/aup+2.3%47n/a5.15No estimate
MARKSANS Marksans Pharma LtdHealthcare560n/adown−4.4%78n/a1.73No estimate
ERIS ERIS Lifesciences LtdHealthcare551n/aup+13.4%80n/a5.22No estimate
PFIZER Pfizer LtdHealthcare547n/aup+1.3%179n/a39.10No estimate
ALIVUS Alivus Life Sciences LtdHealthcare537n/adown−6.3%98n/a7.99No estimate
INDSWFTLAB Ind-Swift Laboratories LtdHealthcare529n/aup+83.7%494n/a83.55No estimate
HIKAL Hikal LtdHealthcare514n/aup+14.9%34n/a2.75No estimate
SANOFI Sanofi India LtdHealthcare511n/aup+9.0%137n/a59.39No estimate
AARTIPHARM Aarti Pharmalabs LtdHealthcare506n/aup+12.7%65n/a7.20No estimate
IOLCP IOL Chemicals & Pharmaceuticals LtdHealthcare504n/adown−3.1%28n/a0.96No estimate
FDC FDC LtdHealthcare462n/aup+0.9%46n/a2.84No estimate
CAPLIPOINT Caplin Point Laboratories LtdHealthcare453n/aup+3.9%121n/a16.01No estimate
INDOCO Indoco Remedies LtdHealthcare450n/adown−2.0%22n/a2.46No estimate
NECLIFE Nectar Lifescience LtdHealthcare441n/adown−2.4%1n/a0.03No estimate
SAILIFE Sai Life Sciences LtdHealthcare439n/aup+14.3%56n/a—No estimate
UNICHEMLAB Unichem Laboratories LtdHealthcare432n/adown−7.3%−129n/a−18.37No estimate
MOREPENLAB Morepen Laboratories LtdHealthcare423n/adown−4.9%29n/a0.55No estimate
NEULANDLAB Neuland Laboratories LtdHealthcare385n/adown−2.0%68n/a52.66No estimate
ASTRAZEN Astrazeneca Pharma India LtdHealthcare383n/aup+25.2%39n/a15.79No estimate
POLYMED Poly Medicure LtdHealthcare378n/aup+11.2%68n/a7.12No estimate
VIYASH Viyash Scientific LtdHealthcare361n/aup+9.7%1n/a−0.04No estimate
CONCORDBIO Concord Biotech LtdHealthcare319n/aup+32.4%97n/a9.29No estimate
SOLARA Solara Active Pharma Sciences LtdHealthcare299n/aup+41.0%−255n/a−53.20No estimate
SHILPAMED Shilpa Medicare LtdHealthcare292n/aup+1.7%24n/a1.41No estimate
INNOVACAP Innova Captab LtdHealthcare263n/adown−12.9%29n/a5.02No estimate
COHANCE Cohance Lifesciences LtdHealthcare253n/aup+15.0%53n/a2.10No estimate
PGHL Procter & Gamble Health LtdHealthcare252n/adown−18.7%47n/a28.05No estimate
SMSPHARMA SMS Pharmaceuticals LtdHealthcare246n/aup+52.8%17n/a2.04No estimate
ACUTAAS Acutaas Chemicals LtdHealthcare225n/aup+35.5%26n/a3.41No estimate
SANOFICONR Sanofi Consumer Healthcare India LtdHealthcare222n/adown−1.3%63n/a—No estimate
ORCHPHARMA Orchid Pharma LtdHealthcare217n/adown−1.6%33n/a6.50No estimate
AAREYDRUGS Aarey Drugs & Pharmaceuticals LtdHealthcare210n/aup+175.0%2n/a0.77No estimate
BI Bilcare LtdHealthcare200n/aup+14.3%−20n/a−4.63No estimate
BLISSGVS Bliss GVS Pharma LtdHealthcare198n/adown−1.5%−5n/a−0.87No estimate
GUFICBIO Gufic BioSciences LtdHealthcare195n/adown−3.5%20n/a2.00No estimate
VENUSREM Venus Remedies LtdHealthcare195n/aup+36.4%11n/a7.86No estimate
KOPRAN Kopran LtdHealthcare186n/aup+17.1%19n/a3.86No estimate
REMUS Remus Pharmaceuticals LtdHealthcare185n/an/a19n/a13.16No estimate
BLUEJET Blue Jet Healthcare LtdHealthcare184n/aup+10.2%40n/a2.29No estimate
WINDLAS Windlas Biotech LtdHealthcare171n/aup+5.6%17n/a8.15No estimate
ANUHPHR Anuh Pharma LtdHealthcare164n/adown−4.7%15n/a1.53No estimate
ADVENZYMES Advanced Enzyme Technologies LtdHealthcare158n/adown−1.9%30n/a2.53No estimate
SUPRIYA Supriya Lifescience LtdHealthcare158n/aup+12.9%37n/a4.59No estimate
Tonira Pharma Ltd(merged) Healthcare146up+9.0%up+37.7%14down−6.7%1.99No estimate
LINCOLN Lincoln Pharmaceuticals LtdHealthcare142n/adown−2.7%19n/a9.29No estimate
WANBURY Wanbury LtdHealthcare139n/adown−4.2%8n/a2.47No estimate
PANACEABIO Panacea Biotec LtdHealthcare136n/adown−9.3%−2n/a−0.32No estimate
INDSWFTLTD Ind-Swift Ltd(Merged)Healthcare135up+27.4%up+31.1%38down−28.3%6.93No estimate
BAJAJHCARE Bajaj Healthcare LtdHealthcare134n/aup+22.9%−30n/a−10.84No estimate
AMRUTANJAN Amrutanjan Health Care LtdHealthcare127n/aup+8.6%14n/a4.72No estimate
RPGLIFE RPG Life Sciences LtdHealthcare127n/adown−17.5%13n/a8.01No estimate
Brabourne Enterprises Ltd(merged) Healthcare124n/adown−1.6%47n/a45.22No estimate
FREDUN Fredun Pharmaceuticals LtdHealthcare118n/aup+35.6%5n/a3.59No estimate
ZIMLAB Zim Laboratories LtdHealthcare118n/aup+22.4%8n/a1.66No estimate
TARSONS Tarsons Products LtdHealthcare106n/aup+71.1%10n/a1.94No estimate
SIGACHI Sigachi Industries LtdHealthcare104n/adown−6.1%15n/a0.46No estimate
MANGALAM Mangalam Drugs and Organics LtdHealthcare102n/aup+5.0%4n/a2.24No estimate
CHANDRABHAGATPHARMALTD Healthcare102up+36.0%n/a10.0%1.19No estimate
SENORES Senores Pharmaceuticals LtdHealthcare102n/aup+29.1%14n/a5.23No estimate
MHHL Mohini Health & Hygiene LtdHealthcare98up+5.4%n/a6up+200.0%3.07No estimate
THEMISMED Themis Medicare LtdHealthcare98n/aup+18.1%7n/a0.72No estimate
FERMENTA Fermenta Biotech LtdHealthcare97n/adown−1.6%−7n/a−2.36No estimate
NGLFINE NGL Fine Chem LtdHealthcare96n/aup+12.9%11n/a17.56No estimate
BALPHARMA Bal Pharma LtdHealthcare95n/aup+15.9%6n/a3.46No estimate
KPL Kwality Pharmaceuticals LtdHealthcare92n/aup+17.9%4n/a4.20No estimate
HALEOSLABS Haleos Labs LimitedHealthcare90n/aup+24.9%6n/a19.52No estimate
ALBERTDAVD Albert David LtdHealthcare89n/aup+1.1%13n/a22.62No estimate
SAMRATPHARMACHEMLTD Healthcare83n/aup+34.1%1n/a4.53No estimate
OSELDEVICE OSEL Devices LtdHealthcare82n/an/a8n/a6.70No estimate

About Q4 FY24 earnings data

When are Q4 FY24 results announced?
Q4 FY24 covers the Jan–Mar 2024 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.
Why do some Q4 FY24 growth figures show "n/a" instead of a percentage?
Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.
Does the beat/miss verdict cover every company?
No analyst consensus was available for Q4 FY24, so no beat/miss verdict is shown. Revenue and profit growth are taken from reported results and cover every company in the table.
What counts as an in-line result rather than a beat or a miss?
Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.
Are the figures consolidated or standalone?
Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.
What does the 8-quarter trend line show?
Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.
How do I find only the companies that beat estimates in Q4 FY24?
Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.